All Pharma News
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule
BUSINESSWIRE
28 Jun 2024
Share Share
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
BUSINESSWIRE
28 Jun 2024
Share Share
US FDA approves expanded use of Sarepta`s Duchenne gene therapy; shares jump

US FDA approves expanded use of Sarepta`s Duchenne gene therapy; shares jump
Leroy Leo REUTERS
21 Jun 2024
Share Share
Great Point Partners acquires German CDMO Lyocontract

Great Point Partners acquires German CDMO Lyocontract
Fraiser Kansteiner FIERCE PHARMA
13 Jun 2024
Share Share
Sarepta Announces Inducement Grants Per Nasdaq Rule

Sarepta Announces Inducement Grants Per Nasdaq Rule
BUSINESSWIRE
31 May 2024
Share Share
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy

Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
Tyler Patchen BIOSPACE
08 May 2024
Share Share
Sarepta Therapeutics executive sells $508,900 in stock

Sarepta Therapeutics executive sells $508,900 in stock
INVESTING
07 May 2024
Share Share
Gene Therapy Pioneer Mendell Named To TIME100 Health List

Gene Therapy Pioneer Mendell Named To TIME100 Health List
BUSINESSWIRE
03 May 2024
Share Share
ICER pushes back on FDA`s potential of Sarepta`s gene therapy to full approval

ICER pushes back on FDA`s potential of Sarepta`s gene therapy to full approval
Lia DeGroot ENDPTS
02 May 2024
Share Share
Sarepta Q1 2024 Results, Recent Corporate Developments

Sarepta Q1 2024 Results, Recent Corporate Developments
BUSINESSWIRE
01 May 2024
Share Share